 TORONTO, April 14, 2021 GLOBE NEWSWIRE -- Profound Medical Corp. NASDAQ:PROF; TSX:PRN Profound or the Company, a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will present an update on the Companys business at the 2021 Bloom Burton Co. Virtual Healthcare Investor Conference on Wednesday, April 21, 2021 at 1:30 p.m. ET. 